Skip to content
Gold Mining News – Lifestyle
Home
Sample Page
Author:
Amplia Therapeutics Limited
Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online
July 31, 2026
Amplia Announces Publication of New FAK Inhibitor Patent Application
July 9, 2026
Amplia Announces Appointment of Brett Carter to Board
July 7, 2026
Amplia Announces Changes to Board’s Leadership Roles
July 6, 2026
Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer
June 22, 2026